EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Microfluidic vessel-on-chip platform for investigation of cellular defects in venous malformations and responses to various shear stress and flow conditions

Mohammadhassan Ansarizadeh, Hoang-Tuan Nguyen iD, Bojana Lazovic, Jere Kettunen, Laknee De Silva, Ragul Sivakumar, Pauliina Junttila, Siiri-Liisa Rissanen, Ryan Hicks, Prateek Singh, Lauri Eklund

Lab on a Chip · 2025

DOI: 10.1039/d4lc00824c ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lab on a Chip, 2025. Verfasst von Mohammadhassan Ansarizadeh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Oulu Center for Cell-Matrix Research, Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, P.O. Box 5000, FI-90014 …. Hauptthemen laut MEDLINE: Stress, Mechanical, Lab-On-A-Chip Devices, Veins, Vascular Malformations. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Horizon 2020 Framework Programme, Finnish Cultural Foundation, Research Council of Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In-line shear stress modulation and cell microscopic analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stress, MechanicalLab-On-A-Chip DevicesVeinsVascular MalformationsMicrofluidic Analytical TechniquesHumansHuman Umbilical Vein Endothelial CellsInduced Pluripotent Stem CellsReceptor, TIE-2Shear Strength

Substanzen

Receptor, TIE-2

Autor:innen und Institutionen

  • Oulu Center for Cell-Matrix Research, Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, P.O. Box 5000, FI-90014 Oulu, Finland. lauri.eklund@oulu.fi.
  • Finnadvance Ltd., Oulu, Finland.
  • BioPharmaceuticals R&D Cell Therapy Department, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Translational Genomics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK.

ORCID-Profile: Hoang-Tuan Nguyen

Förderung

  • Horizon 2020 Framework Programme
  • Finnish Cultural Foundation
  • Research Council of Finland

Zitieren

APA

Ansarizadeh, M., Nguyen, H. T., Lazovic, B., Kettunen, J., De Silva, L., Sivakumar, R., Junttila, P., Rissanen, S. L., Hicks, R., Singh, P., & Eklund, L. (2025). Microfluidic vessel-on-chip platform for investigation of cellular defects in venous malformations and responses to various shear stress and flow conditions. Lab on a Chip. https://doi.org/10.1039/d4lc00824c

Vancouver

Ansarizadeh M, Nguyen HT, Lazovic B, Kettunen J, De Silva L, Sivakumar R, et al. Microfluidic vessel-on-chip platform for investigation of cellular defects in venous malformations and responses to various shear stress and flow conditions. Lab on a Chip. 2025. doi:10.1039/d4lc00824c

BibTeX
@article{Ansarizadeh2025,
  author = {Ansarizadeh, Mohammadhassan and Nguyen, Hoang-Tuan and Lazovic, Bojana and Kettunen, Jere and De Silva, Laknee and Sivakumar, Ragul and Junttila, Pauliina and Rissanen, Siiri-Liisa and Hicks, Ryan and Singh, Prateek and Eklund, Lauri},
  title = {Microfluidic vessel-on-chip platform for investigation of cellular defects in venous malformations and responses to various shear stress and flow conditions},
  journal = {Lab on a Chip},
  year = {2025},
  doi = {10.1039/d4lc00824c}
}
Kostenlos starten →